Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Perou

Showing results (431-440 of 476) with videos related to

Pageof 48
Sort By:
JCO Precision Oncology|July 9, 2025
Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL TrialYash N Agrawal, Aranzazu Fernández-Martínez, Miguel Gil-Gil, et al.
Science (New York, N.Y.)|July 21, 2018
VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinomaJing Zhang, Tao Wu, Jeremy Simon, et al.
Cell|October 10, 2015
Comprehensive Molecular Portraits of Invasive Lobular Breast CancerGiovanni Ciriello, Michael L Gatza, Andrew H Beck, et al.
The Journal of Pathology|November 19, 2016
The molecular basis of breast cancer pathological phenotypesYujing J Heng, Susan C Lester, Gary Mk Tse, et al.
ESMO Open|January 7, 2025
Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancerL Angelats, L Paré, C Rubio-Perez, et al.
Nature Communications|January 29, 2020
Microscaled proteogenomic methods for precision oncologyShankha Satpathy, Eric J Jaehnig, Karsten Krug, et al.
Nature Cancer|February 12, 2024
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilitiesYi-Zhou Jiang, Ding Ma, Xi Jin, et al.
Nature Communications|September 3, 2021
Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancerNathan F Schachter, Jessica R Adams, Patryk Skowron, et al.
NPJ Breast Cancer|May 13, 2021
FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036Steven P Angus, Timothy J Stuhlmiller, Gaurav Mehta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2022
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast CancerJonathan H Shepherd, Karla Ballman, Mei-Yin C Polley, et al.
Pageof 48

Showing results (431-440 of 476) with videos related to

Sort By:
Pageof 48
JCO Precision Oncology|July 9, 2025
Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL TrialYash N Agrawal, Aranzazu Fernández-Martínez, Miguel Gil-Gil, et al.
Science (New York, N.Y.)|July 21, 2018
VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinomaJing Zhang, Tao Wu, Jeremy Simon, et al.
Cell|October 10, 2015
Comprehensive Molecular Portraits of Invasive Lobular Breast CancerGiovanni Ciriello, Michael L Gatza, Andrew H Beck, et al.
The Journal of Pathology|November 19, 2016
The molecular basis of breast cancer pathological phenotypesYujing J Heng, Susan C Lester, Gary Mk Tse, et al.
ESMO Open|January 7, 2025
Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancerL Angelats, L Paré, C Rubio-Perez, et al.
Nature Communications|January 29, 2020
Microscaled proteogenomic methods for precision oncologyShankha Satpathy, Eric J Jaehnig, Karsten Krug, et al.
Nature Cancer|February 12, 2024
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilitiesYi-Zhou Jiang, Ding Ma, Xi Jin, et al.
Nature Communications|September 3, 2021
Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancerNathan F Schachter, Jessica R Adams, Patryk Skowron, et al.
NPJ Breast Cancer|May 13, 2021
FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036Steven P Angus, Timothy J Stuhlmiller, Gaurav Mehta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2022
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast CancerJonathan H Shepherd, Karla Ballman, Mei-Yin C Polley, et al.
Pageof 48